Literature DB >> 16595695

A double Holliday junction dissolvasome comprising BLM, topoisomerase IIIalpha, and BLAP75.

Steven Raynard1, Wendy Bussen, Patrick Sung.   

Abstract

Bloom syndrome (BS), an autosomal recessive disorder, is marked by a high incidence of cancer early in life. Cells derived from BS patients are unstable genetically and exhibit frequent sister chromatid exchanges, reflective of homologous recombination (HR) deregulation. BLM, the RecQ-like helicase mutated in BS, is found in several cellular protein complexes, all of which contain topoisomerase IIIalpha (Topo IIIalpha) and a novel protein BLAP75. Here, using highly purified human proteins, we show that BLAP75 associates independently with both Topo IIIalpha and BLM. Even though BLM and Topo IIIalpha can dissolve the double Holliday junction (DHJ) to yield non-crossover recombinants (1), under physiological conditions, DHJ dissolution becomes completely dependent on BLAP75. The effect of BLAP75 on BLM-Topo IIIalpha is highly specific, as it is not seen with the combination of Topo IIIalpha and Escherichia coli RecQ helicase or another human RecQ-like helicase WRN. Thus, BLM, Topo IIIalpha, and BLAP75 constitute a dissolvasome complex that processes HR intermediates to limit DNA crossover formation. This function of the BLM-Topo IIIalpha-BLAP75 dissolvasome is likely indispensable for genome maintenance and cancer avoidance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595695     DOI: 10.1074/jbc.C600051200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  133 in total

1.  Polarity and bypass of DNA heterology during branch migration of Holliday junctions by human RAD54, BLM, and RECQ1 proteins.

Authors:  Olga M Mazina; Matthew J Rossi; Julianna S Deakyne; Fei Huang; Alexander V Mazin
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  RMI1 promotes DNA replication fork progression and recovery from replication fork stress.

Authors:  Jay Yang; Lara O'Donnell; Daniel Durocher; Grant W Brown
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 3.  Pathways of mammalian replication fork restart.

Authors:  Eva Petermann; Thomas Helleday
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-15       Impact factor: 94.444

4.  Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication.

Authors:  Dongyi Xu; Parameswary Muniandy; Elisabetta Leo; Jinhu Yin; Saravanabhavan Thangavel; Xi Shen; Miki Ii; Keli Agama; Rong Guo; David Fox; Amom Ruhikanta Meetei; Lauren Wilson; Huy Nguyen; Nan-ping Weng; Steven J Brill; Lei Li; Alessandro Vindigni; Yves Pommier; Michael Seidman; Weidong Wang
Journal:  EMBO J       Date:  2010-08-13       Impact factor: 11.598

Review 5.  DNA replication stress: from molecular mechanisms to human disease.

Authors:  Sergio Muñoz; Juan Méndez
Journal:  Chromosoma       Date:  2016-01-21       Impact factor: 4.316

Review 6.  The role of post-translational modifications in fine-tuning BLM helicase function during DNA repair.

Authors:  Stefanie Böhm; Kara Anne Bernstein
Journal:  DNA Repair (Amst)       Date:  2014-08-24

7.  Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population.

Authors:  Li-Qiang Zhi; Wei Ma; Hong Zhang; Si-Xiang Zeng; Bo Chen
Journal:  Tumour Biol       Date:  2013-11-28

8.  Rmi1, a member of the Sgs1-Top3 complex in budding yeast, contributes to sister chromatid cohesion.

Authors:  Mong Sing Lai; Masayuki Seki; Ayako Ui; Takemi Enomoto
Journal:  EMBO Rep       Date:  2007-06-15       Impact factor: 8.807

9.  RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures.

Authors:  Venkateswarlu Popuri; Deborah L Croteau; Robert M Brosh; Vilhelm A Bohr
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

10.  Haplotype analysis of RECQL5 gene and laryngeal cancer.

Authors:  Ying Qi; Xu Zhou
Journal:  Tumour Biol       Date:  2013-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.